What are Acute Kidney Injury biomarkers
Acute kidney injury (AKI) biomarkers are molecules in the blood that signal how well the kidneys are filtering and whether their cells are under stress or damaged. They let clinicians detect a sudden drop in kidney function quickly and understand what kind of problem is unfolding. Some biomarkers reflect filtration—the kidney’s sieving job—such as creatinine (a muscle byproduct), urea nitrogen (BUN), and cystatin C (a small protein made steadily by most cells). Others reflect injury inside the kidney’s tubules, the tiny pipes that process filtered fluid. These include NGAL (neutrophil gelatinase–associated lipocalin), which is released by stressed tubular cells, and proenkephalin A (penKid), a stable fragment that tracks real-time filtering capacity. Beta-2 microglobulin (β2M) can also indicate changes in filtration and tubular handling. Together, these blood signals help distinguish poor filtration from direct tubular injury, reveal AKI earlier than symptoms, and support timely decisions about fluids, medicines, and when to protect the kidneys from further harm.
Why is blood testing for Acute Kidney Injury important?
- Check kidney filtration now and flag acute kidney injury using creatinine, eGFR, and BUN.
- Spot early kidney stress and flag when rapid, urgent care is needed.
- Distinguish low blood flow problems from kidney tissue injury using BUN/Creatinine ratio.
- Clarify dehydration versus blockage to direct fluids or imaging promptly.
- Guide safe medication dosing and avoid kidney-harming drugs, contrast dyes, and NSAIDs.
- Protect pregnancy by detecting filtration changes tied to preeclampsia and medication safety needs.
- Track recovery after illness, surgery, infection, or contrast exposure to ensure kidneys rebound.
- Interpret results best with urine output, urinalysis, prior creatinine, and symptoms context.
What insights will I get?
Acute Kidney Injury (AKI) blood testing is essential because the kidneys play a central role in filtering waste, balancing fluids, and regulating blood pressure—functions that impact energy, metabolism, cardiovascular health, cognition, and immunity. When kidney function is disrupted, waste products can build up quickly, affecting nearly every system in the body. At Superpower, we assess AKI risk and status using four key biomarkers: Creatinine, estimated Glomerular Filtration Rate (eGFR), Blood Urea Nitrogen (BUN), and the BUN/Creatinine Ratio.
Creatinine is a waste product from muscle metabolism, and its blood level rises when the kidneys are not filtering efficiently. eGFR is a calculated value that estimates how well the kidneys are clearing creatinine from the blood, providing a direct measure of kidney filtration capacity. BUN reflects the amount of nitrogen in the blood from urea, another waste product filtered by the kidneys. The BUN/Creatinine Ratio helps distinguish between different causes of kidney dysfunction, such as dehydration versus direct kidney injury.
Together, these markers reveal how stable and effective your kidneys are at maintaining internal balance. Healthy values suggest the kidneys are efficiently clearing waste and supporting overall system stability. Abnormal results may indicate acute stress or injury to the kidneys, which can disrupt fluid, electrolyte, and toxin balance, with downstream effects on heart, brain, and immune function.
Interpretation of these biomarkers can be influenced by factors such as age, pregnancy, muscle mass, recent illness, certain medications, and laboratory assay differences. These variables are important to consider for accurate assessment of kidney health.





.avif)










.avif)






.avif)
.avif)
.avif)


.avif)
.avif)


.avif)


